Product Information
EZETIMIBE 10 MG TABLET is a generic product labeled by ScieGen Pharmaceuticals Inc., priced at $0.0675 per EA under NDC 50228037930. Its NADAC has been published 260 times since Sep 1, 2021.
FDA first approved this application on Oct 23, 2020. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
10 mg/1
Manufacturer
ScieGen Pharmaceuticals Inc.NDC
50228037930
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
EZETIMIBEApproval Type
Generic (ANDA)
FDA Application
ANDA210673FDA Approved
10/23/2020
TE Code
AB
On Market Since
10/23/2020
Pharmacological Classes
Price Statistics
The NADAC for EZETIMIBE 10 MG TABLET has been published 260 times since Sep 1, 2021, and over the history we have for it it has declined 54.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0675 per EA |
|---|---|
| All-time high | $0.1542 (Dec 15, 2021) |
| All-time low | $0.0672 (Jul 22, 2026) |
| 52-week high | $0.0756 |
| 52-week low | $0.0672 |
| Median price | $0.0854 |
| Average price | $0.0902 |
| Largest weekly change | +22.7% (Jun 19, 2024) |
| Weeks tracked | 260 |
| Tracking since | Sep 1, 2021 |
Generic Alternatives
The matcher finds 13 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 0% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of EZETIMIBE 10 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for EZETIMIBE 10 MG TABLET, manufactured by ScieGen Pharmaceuticals Inc., is $0.0675 per EA (NDC 50228037930), effective Aug 19, 2026.
How has the price of EZETIMIBE 10 MG TABLET changed over time?
Over the history we have for it, the NADAC for EZETIMIBE 10 MG TABLET has declined 54.3%. It has been tracked across 260 weekly CMS publications since Sep 1, 2021.
What are the highest and lowest recorded NADAC prices for EZETIMIBE 10 MG TABLET?
Since Sep 1, 2021, the NADAC for EZETIMIBE 10 MG TABLET has ranged from a low of $0.0672 (Jul 22, 2026) to a high of $0.1542 (Dec 15, 2021), with a median of $0.0854 per EA.
Are there cheaper alternatives to EZETIMIBE 10 MG TABLET?
Yes. 13 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, EZETIMIBE 10 MG TABLET, is $0.0672 per EA — about 0% below EZETIMIBE 10 MG TABLET.
Who manufactures EZETIMIBE 10 MG TABLET?
EZETIMIBE 10 MG TABLET (NDC 50228037930) is labeled by ScieGen Pharmaceuticals Inc., and CMS classifies it as a generic product.